Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save ₹3,540 crore/year

According to the Ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026